Status:
COMPLETED
Evaluating the Effect of Cromolyn Sodium in Uremic Pruritus
Lead Sponsor:
Shiraz University of Medical Sciences
Conditions:
End Stage Renal Disease
Pruritus
Eligibility:
All Genders
18-75 years
Phase:
PHASE2
Brief Summary
Pruritus is a major disorder among the skin derangements in advanced renal failure. Recent information suggests that interactions between dermal mast cells and distal ends of nonmyelinated C fibers ma...
Eligibility Criteria
Inclusion
- Hemodialysis patients \> 18 yo suffering from pruritus for at least 6 weeks, and who have not responded to other drugs
- Willing and able to give informed concent
Exclusion
- Known dermatologic, liver, metabolic disease, or any other disease or condition other than ESRD that causes pruritus
- Lactase deficiency
Key Trial Info
Start Date :
May 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2009
Estimated Enrollment :
62 Patients enrolled
Trial Details
Trial ID
NCT00745199
Start Date
May 1 2008
End Date
June 1 2009
Last Update
August 18 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shiraz University of Medical sciences, Nemazi and Faghihi Hospital
Shiraz, Fars, Iran, 71345